Efficacy of topical brinzolamide treatment in posterior microphthalmos-related macular cystoid lesions: A case series

dc.contributor.authorEngin C.D.
dc.contributor.authorEkinci U.B.
dc.contributor.authorSelver A.
dc.contributor.authorSaatçi A.O.
dc.date.accessioned2025-04-10T11:06:58Z
dc.date.available2025-04-10T11:06:58Z
dc.date.issued2020
dc.description.abstractThe aim of this study was to report the outcome of topical brinzolamide 1% treatment on macular cystoid lesions resembling retinoschisis in 4 patients diagnosed with posterior microphthalmia. The medical records of 4 patients with a clinical diagnosis of posterior microphthalmia who had started topical brinzolamide 1% treatment were reviewed. Visual acuity, central foveal thickness, and cystoid lesion area percentage were used to evaluate treatment response. In the follow-up, there was a decrease in central foveal thicknesses and cystoid lesion area percentages in both eyes of 3 of the patients. However, 1 patient showed increases in both parameters. Visual acuity remained stable in 5 eyes and increased in 3 eyes. Topical brinzolamide treatment may have some positive effects on macular cystoid lesions in selected cases. © 2020 by Turkish Ophthalmological Association Turkish Journal of Ophthalmology, published by Galenos Publishing House.
dc.identifier.DOI-ID10.4274/tjo.galenos.2019.40504
dc.identifier.urihttp://hdl.handle.net/20.500.14701/47085
dc.publisherTurkish Ophthalmology Society
dc.titleEfficacy of topical brinzolamide treatment in posterior microphthalmos-related macular cystoid lesions: A case series
dc.typeArticle

Files